A novel cell-permeable RDP-p53 fusion protein for specific inhibition on the growth of cancerous neural cells

Six-cell penetrating peptide-based fusion proteins for siRNA delivery

(2014) Hua Li et al.   DRUG DELIVERY

p28, an Anionic Cell-Penetrating Peptide, Increases the Activity of Wild Type and Mutated p53 without Altering Its Conformation

(2013) Tohru Yamada et al.   MOLECULAR PHARMACEUTICS

Cellular Uptake Mechanism and Therapeutic Utility of a Novel Peptide in Targeted-Delivery of Proteins into Neuronal Cells

(2013) Ailing Fu et al.   PHARMACEUTICAL RESEARCH

A Novel Peptide Delivers Plasmids across Blood-Brain Barrier into Neuronal Cells as a Single-Component Transfer Vector

(2013) Ailing Fu et al.   PLoS One

Expression and purification of human TAT-p53 fusion protein in Pichia pastoris and its influence on HepG2 cell apoptosis

(2012) Haowei Yan et al.   BIOTECHNOLOGY LETTERS

Drug Transport across the Blood–Brain Barrier

(2012) William M Pardridge   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Targeted Delivery of Proteins into the Central Nervous System Mediated by Rabies Virus Glycoprotein-Derived Peptide

(2012) Ailing Fu et al.   PHARMACEUTICAL RESEARCH

Comparative analysis of the methods of drug and protein delivery for the treatment of cancer, genetic diseases and diagnostics

(2011) Roumiana Todorova   DRUG DELIVERY

The role of mutant p53 in human cancer

(2010) Amanda M Goh et al.   JOURNAL OF PATHOLOGY

Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics

(2009) Frederic Heitz et al.   BRITISH JOURNAL OF PHARMACOLOGY

A recombinant cell-permeable p53 fusion protein is selectively stabilized under hypoxia and inhibits tumor cell growth

(2009) Zhao Yu et al.   CANCER LETTERS

The cell death machinery governed by the p53 tumor suppressor in response to DNA damage

(2009) Kiyotsugu Yoshida et al.   CANCER SCIENCE

Dual-Targeting Topotecan Liposomes Modified with Tamoxifen and Wheat Germ Agglutinin Significantly Improve Drug Transport across the Blood−Brain Barrier and Survival of Brain Tumor-Bearing Animals

(2009) Ju Du et al.   MOLECULAR PHARMACEUTICS

Cytoplasmic functions of the tumour suppressor p53

(2009) Douglas R. Green et al.   NATURE

Engineering, expression, and immuno-characterization of recombinant protein comprising multi-neutralization sites of rabies virus glycoprotein

(2009) Xiangdong Li et al.   PROTEIN EXPRESSION AND PURIFICATION

Apigenin causes G2/M arrest associated with the modulation of p21Cip1 and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells

(2008) Eun Jeong Choi et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY